JP2013501047A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013501047A5 JP2013501047A5 JP2012523650A JP2012523650A JP2013501047A5 JP 2013501047 A5 JP2013501047 A5 JP 2013501047A5 JP 2012523650 A JP2012523650 A JP 2012523650A JP 2012523650 A JP2012523650 A JP 2012523650A JP 2013501047 A5 JP2013501047 A5 JP 2013501047A5
- Authority
- JP
- Japan
- Prior art keywords
- atoms
- hal
- nhco
- conh
- nhconh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 claims 4
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 4
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 4
- 125000004430 oxygen atom Chemical group O* 0.000 claims 4
- 125000004434 sulfur atom Chemical group 0.000 claims 4
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 125000004429 atom Chemical group 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 125000002950 monocyclic group Chemical group 0.000 claims 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 1
- 229940002612 prodrug Drugs 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23187309P | 2009-08-06 | 2009-08-06 | |
| US61/231,873 | 2009-08-06 | ||
| PCT/US2010/043467 WO2011017142A1 (en) | 2009-08-06 | 2010-07-28 | Novel bicyclic urea compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013501047A JP2013501047A (ja) | 2013-01-10 |
| JP2013501047A5 true JP2013501047A5 (enExample) | 2013-09-12 |
| JP5718332B2 JP5718332B2 (ja) | 2015-05-13 |
Family
ID=42985363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012523650A Expired - Fee Related JP5718332B2 (ja) | 2009-08-06 | 2010-07-28 | 新規な二環式尿素化合物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8569295B2 (enExample) |
| EP (1) | EP2461869B1 (enExample) |
| JP (1) | JP5718332B2 (enExample) |
| KR (1) | KR20120055608A (enExample) |
| CN (1) | CN102573994B (enExample) |
| AU (1) | AU2010281368C1 (enExample) |
| CA (1) | CA2770156C (enExample) |
| EA (1) | EA201200218A1 (enExample) |
| ES (1) | ES2433230T3 (enExample) |
| IL (1) | IL217651A (enExample) |
| MX (1) | MX2012001419A (enExample) |
| SG (1) | SG178271A1 (enExample) |
| WO (1) | WO2011017142A1 (enExample) |
| ZA (1) | ZA201201635B (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2599458T3 (es) | 2008-10-14 | 2017-02-01 | Sunshine Lake Pharma Co., Ltd. | Compuestos y métodos de uso |
| EP2408300B1 (en) | 2009-03-21 | 2016-05-11 | Sunshine Lake Pharma Co., Ltd. | Amino ester derivatives, salts thereof and methods of use |
| US9290485B2 (en) | 2010-08-04 | 2016-03-22 | Novartis Ag | N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides |
| RU2568258C2 (ru) | 2011-02-28 | 2015-11-20 | Саншайн Лейк Фарма Ко., Лтд | Замещенные соединения хинолина и способы их использования |
| WO2013022519A1 (en) * | 2011-08-10 | 2013-02-14 | Merck Patent Gmbh | Pyrido-pyrimidine derivatives |
| GB201201566D0 (en) * | 2012-01-30 | 2012-03-14 | Vernalis R&D Ltd | New chemical compounds |
| US8975282B2 (en) | 2012-07-28 | 2015-03-10 | Sunshine Lake Pharma Co., Ltd. | Substituted pyrazolone compounds and methods of use |
| JP6342392B2 (ja) | 2012-07-28 | 2018-06-13 | カリター・サイエンシーズ・エルエルシー | 置換型ピラゾロン化合物及び使用方法 |
| US20150225369A1 (en) | 2012-08-29 | 2015-08-13 | Merck Patent Gmbh | Ddr2 inhibitors for the treatment of osteoarthritis |
| SG10202103278TA (en) | 2013-10-14 | 2021-04-29 | Eisai R&D Man Co Ltd | Selectively substituted quinoline compounds |
| ES2670550T3 (es) | 2013-10-14 | 2018-05-30 | Eisai R&D Management Co., Ltd. | Derivados de quinolina selectivamente sustituidos |
| CN106279147A (zh) * | 2015-05-21 | 2017-01-04 | 中国科学院上海药物研究所 | 一种吡啶并氮杂环化合物及其制备方法和用途 |
| WO2017174879A1 (en) * | 2016-04-06 | 2017-10-12 | University Of Oulu | Compounds for use in the treatment of cancer |
| AU2018272986A1 (en) * | 2017-05-26 | 2019-12-12 | Ichnos Sciences SA | Novel inhibitors of MAP4K1 |
| GB2575490A (en) * | 2018-07-12 | 2020-01-15 | Recordati Ind Chimica E Farmaceutica Spa | P2X3 receptor antagonists |
| ES2985569T3 (es) * | 2018-08-24 | 2024-11-06 | Transthera Sciences Nanjing Inc | Nuevo inhibidor de derivado de quinolina |
| CA3129722A1 (en) * | 2019-02-11 | 2020-08-20 | Phoenix Molecular Designs | Crystalline forms of an rsk inhibitor |
| CN112625026B (zh) * | 2019-09-24 | 2022-09-09 | 药捷安康(南京)科技股份有限公司 | Tam家族激酶抑制剂的喹啉衍生物 |
| BR112022019517A2 (pt) | 2020-03-30 | 2022-12-06 | Hutchison Medipharma Ltd | Compostos de amida e usos dos mesmos |
| CN112225748B (zh) * | 2020-10-20 | 2021-11-30 | 四川大学华西医院 | 一种具有flt3激酶抑制活性的小分子化合物及其应用 |
| WO2022175514A1 (en) | 2021-02-22 | 2022-08-25 | Bayer Aktiengesellschaft | N-(pyridin-2-yl)-acetamides as p2x3 inhibitors |
| KR102726416B1 (ko) * | 2021-12-15 | 2024-11-05 | 한국과학기술연구원 | 엑토뉴클레오티드 피로포스파타아제-포스포디에스터라아제의 저해 활성을 갖는 신규한 피리도피리미딘 유도체 및 이들의 용도 |
| WO2023114809A1 (en) | 2021-12-16 | 2023-06-22 | Kinnate Biopharma Inc. | Inhibitors of met kinase |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA04011579A (es) * | 2002-05-29 | 2005-03-07 | Amgen Inc | Derivados de 2-oxo-2,3,4-trihidroquinazolinilo para el tratamiento de trastornos relacionados con la proliferacion celular. |
| DE102004004731A1 (de) * | 2004-01-30 | 2005-08-18 | Merck Patent Gmbh | Harnstoffderivate |
| CA2600886A1 (en) * | 2005-03-08 | 2006-09-14 | Biota Scientific Management Pty Ltd. | Bicyclic nucleosides and nucleotides as therapeutic agents |
| EP2354140A1 (en) * | 2005-05-20 | 2011-08-10 | Vertex Pharmaceuticals Incorporated | Pyrrolopyridines useful as inhibitors of protein kinase |
-
2010
- 2010-07-28 CN CN201080034738.XA patent/CN102573994B/zh not_active Expired - Fee Related
- 2010-07-28 US US13/388,952 patent/US8569295B2/en not_active Expired - Fee Related
- 2010-07-28 SG SG2012008074A patent/SG178271A1/en unknown
- 2010-07-28 CA CA2770156A patent/CA2770156C/en not_active Expired - Fee Related
- 2010-07-28 MX MX2012001419A patent/MX2012001419A/es unknown
- 2010-07-28 JP JP2012523650A patent/JP5718332B2/ja not_active Expired - Fee Related
- 2010-07-28 EP EP10739442.1A patent/EP2461869B1/en not_active Not-in-force
- 2010-07-28 WO PCT/US2010/043467 patent/WO2011017142A1/en not_active Ceased
- 2010-07-28 ES ES10739442T patent/ES2433230T3/es active Active
- 2010-07-28 KR KR1020127005845A patent/KR20120055608A/ko not_active Withdrawn
- 2010-07-28 EA EA201200218A patent/EA201200218A1/ru unknown
- 2010-07-28 AU AU2010281368A patent/AU2010281368C1/en not_active Ceased
-
2012
- 2012-01-19 IL IL217651A patent/IL217651A/en active IP Right Grant
- 2012-03-05 ZA ZA2012/01635A patent/ZA201201635B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013501047A5 (enExample) | ||
| JP2013518107A5 (enExample) | ||
| JP2010265321A5 (enExample) | ||
| JP2014511891A5 (enExample) | ||
| JP2016503797A5 (enExample) | ||
| JP2013542218A5 (enExample) | ||
| JP2013518832A5 (enExample) | ||
| JP2013527242A5 (enExample) | ||
| JP2016530259A5 (enExample) | ||
| JP2013544860A5 (enExample) | ||
| JP2008510828A5 (enExample) | ||
| AR086095A1 (es) | Derivados de nucleosidos 2’-sustituidos y metodos de uso de los mismos para el tratamiento de enfermedades virales | |
| JP2013542247A5 (enExample) | ||
| JP2018533593A5 (enExample) | ||
| JP2012072150A5 (enExample) | ||
| RU2015118647A (ru) | Аминопиримидиновые соединения в качестве ингибиторов содержащих т790м мутантных egfr | |
| JP2013508279A5 (enExample) | ||
| IN2014CN04127A (enExample) | ||
| JP2017537949A5 (enExample) | ||
| JP2013544276A5 (enExample) | ||
| JP2014500295A5 (enExample) | ||
| JP2015522650A5 (enExample) | ||
| JP2016506961A5 (enExample) | ||
| JP2017504635A5 (enExample) | ||
| JP2017517565A5 (enExample) |